Avid Bioservices Inc (CDMO)

[pphmtoolong]

eb0783, a development company without money doesn't develop anything.

Peregrine has been a development company for twenty plus years with no record of commercial success. And, it has just suffered an early halt to its only Phase III trial.

I still like to think Bavi-immunotherapy will be a significant success. However, given Peregrine's less than stellar track record, I don't see how Peregrine management can expect to raise money via ATM as it did before the Sunrise face plant.

If PPHM shares were only valued at a dollar with a promising Phase III trial nearing completion, how many shares will they have to sell now to fund several years of additional development? Too many. Way too many.

So, my simple conclusion: fund the company with Avid revenue.

GLTA, Paul